Robust T cell immunity in convalescent individuals with asymptomatic or mild COVID-19

Takuya Sekine(Karolinska University Hospital), André Perez‐Potti(Karolinska University Hospital), Olga Rivera‐Ballesteros(Karolinska University Hospital), Kristoffer Strålin(Karolinska University Hospital), Jean‐Baptiste Gorin(Karolinska University Hospital), Annika Olsson(Karolinska University Hospital), Sian Llewellyn‐Lacey(University Hospital of Wales), Habiba Kamal(Karolinska University Hospital), Gordana Bogdanović(Karolinska University Hospital), Sandra Muschiol(Karolinska University Hospital), David Wullimann(Karolinska University Hospital), Tobias Kammann(Karolinska University Hospital), Johanna Emgård(Karolinska University Hospital), Tiphaine Parrot(Karolinska University Hospital), Elin Folkesson(Karolinska University Hospital), Olav Rooyackers(Karolinska University Hospital), Lars I. Eriksson(Karolinska University Hospital), Anders Sönnerborg(Karolinska University Hospital), Tobias Allander(Karolinska University Hospital), Jan Albert(Karolinska University Hospital), Morten Nielsen(National University of General San Martín), Jonas Klingström(Karolinska University Hospital), Sara Gredmark‐Russ(Karolinska University Hospital), Niklas K. Björkström(Karolinska University Hospital), Johan K. Sandberg(Karolinska University Hospital), David A. Price(University Hospital of Wales), Hans‐Gustaf Ljunggren(Karolinska University Hospital), Soo Aleman(Karolinska University Hospital), Marcus Buggert(Karolinska University Hospital), Karolinska COVID-19 Study Group
bioRxiv (Cold Spring Harbor Laboratory)
June 29, 2020
Cited by 293Open Access
Full Text

Abstract

ABSTRACT SARS-CoV-2-specific memory T cells will likely prove critical for long-term immune protection against COVID-19. We systematically mapped the functional and phenotypic landscape of SARS-CoV-2-specific T cell responses in a large cohort of unexposed individuals as well as exposed family members and individuals with acute or convalescent COVID-19. Acute phase SARS-CoV-2-specific T cells displayed a highly activated cytotoxic phenotype that correlated with various clinical markers of disease severity, whereas convalescent phase SARS-CoV-2-specific T cells were polyfunctional and displayed a stem-like memory phenotype. Importantly, SARS-CoV-2-specific T cells were detectable in antibody-seronegative family members and individuals with a history of asymptomatic or mild COVID-19. Our collective dataset shows that SARS-CoV-2 elicits robust memory T cell responses akin to those observed in the context of successful vaccines, suggesting that natural exposure or infection may prevent recurrent episodes of severe COVID-19 also in seronegative individuals.


Related Papers

No related papers found

Powered by citation graph analysis